Avanos Medical reports Q4 and FY2024 results; specific figures not available in filing excerpt

AVANOS MEDICAL, INC.

2024-FY EPS reported -$8.53 revenue$687,800,000

Press release dated February 26, 2025 for the three months and year ended December 31, 2024.
Exhibit 99.1 containing detailed financial data was referenced but not included in the provided text.
Common stock trades on NYSE under ticker AVNS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.